Honestly, what's the impact on the underlying business... i would have thought that the only material impact in the short or medium term would be the ability to attract quality executive and head office staff. (And im not suggesting its unimportant, but it's most important for the long term)
the surgeons will keep using and promoting out outstanding technology. The sales force will continue building relationships with surgeons and hospitals. BARDA will remain an active partner with us. FDA submissions will continue, R&D activity will continue. Etc.
Fes
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
-0.005(0.41%) |
Mkt cap ! $837.6M | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.22 | $1.19 | $1.342M | 1.121M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 41 | 18733 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.21 | 19811 | 20 |
View Market Depth
| Last trade - 13.09pm 18/06/2025 (20 minute delay) ? |
| PNV (ASX) Chart |